Literature DB >> 8300247

Ochrobactrum anthropi bacteremia: report of four cases and short review.

W V Kern1, M Oethinger, A Kaufhold, E Rozdzinski, R Marre.   

Abstract

Ochrobactrum anthropi, formerly "Achromobacter" CDC group Vd, is a nonfermentative, nonfastidious gram-negative bacillus, that only recently has been given attention as a potential human pathogen. Over a 2-year period, we observed four patients with multiple blood cultures that were positive for the organism. The patients had acute leukemia as underlying disease, and presented with clinical and microbiologic features consistent with catheter-related bacteremia. In three of the patients the infection initially appeared to be unrelated to chemotherapy-associated profound neutropenia and occurred early after, or was the reason for, hospital admission. The antimicrobial susceptibility of the isolates varied: unlike previously reported cases, resistance in some of our isolates included aminoglycosides, newer fluoroquinolones, and trimethoprim-sulfamethoxazole. Despite in vitro susceptibility to imipenem in initial isolates, treatment of two patients with this agent obviously failed to eradicate the organism, and the patients either relapsed with bacteremia shortly after discontinuation of treatment or remained persistently febrile and bacteremic. O. anthropi appears to be increasingly recognized as a human opportunist pathogen associated with intravascular catheters and unpredictable multiple antibiotic resistance.

Entities:  

Mesh:

Year:  1993        PMID: 8300247     DOI: 10.1007/BF01712451

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Pseudomonas pickettii infections in a paediatric oncology unit.

Authors:  S Lacey; S V Want
Journal:  J Hosp Infect       Date:  1991-01       Impact factor: 3.926

2.  Bacteremia and urinary tract infection associated with CDC group Vd biovar 2.

Authors:  K G Van Horn; C A Gedris; T Ahmed; G P Wormser
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections.

Authors:  L S Elting; G P Bodey
Journal:  Medicine (Baltimore)       Date:  1990-09       Impact factor: 1.889

Review 4.  Agrobacterium radiobacter: a recently recognized opportunistic pathogen.

Authors:  M B Edmond; S A Riddler; C M Baxter; B M Wicklund; A W Pasculle
Journal:  Clin Infect Dis       Date:  1993-03       Impact factor: 9.079

5.  Outbreak of Pseudomonas cepacia bacteremia in oncology patients.

Authors:  D A Pegues; L A Carson; R L Anderson; M J Norgard; T A Argent; W R Jarvis; C H Woernle
Journal:  Clin Infect Dis       Date:  1993-03       Impact factor: 9.079

6.  Puncture wound osteochondritis of the foot caused by CDC group Vd.

Authors:  W J Barson; B A Cromer; M J Marcon
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

7.  Acinetobacter calcoaceticus septicemia in patients with cancer.

Authors:  K Rolston; Z Guan; G P Bodey; L Elting
Journal:  South Med J       Date:  1985-06       Impact factor: 0.954

8.  [Evolution of Acinetobacter calcoaceticus in the hospital milieu, from 1971 to 1984].

Authors:  M L Joly-Guillou; E Bergogne-Berezin
Journal:  Presse Med       Date:  1985-12-28       Impact factor: 1.228

Review 9.  Xanthomonas maltophilia: an emerging nosocomial pathogen.

Authors:  W F Marshall; M R Keating; J P Anhalt; J M Steckelberg
Journal:  Mayo Clin Proc       Date:  1989-09       Impact factor: 7.616

10.  Pancreatic abscess associated with Achromobacter group Vd biovar 1.

Authors:  P C Appelbaum; D B Campbell
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

View more
  20 in total

1.  Fluorescent whole-cell hybridization with 16S rRNA-targeted oligonucleotide probes to identify Brucella spp. by flow cytometry.

Authors:  L Fernández-Lago; F J Vallejo; I Trujillano; N Vizcaíno
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Effects of atrazine on Ochrobactrum anthropi membrane fatty acids.

Authors:  D Laura; G De Socio; R Frassanito; D Rotilio
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

3.  Genotyping of Ochrobactrum spp. by AFLP analysis.

Authors:  Diana Sara Leal-Klevezas; Octavio Martínez-de-la-Vega; Ector Jaime Ramírez-Barba; Björn Osterman; Juan Pablo Martínez-Soriano; June Simpson
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

4.  Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp.

Authors:  J Velasco; R Díaz; M J Grilló; M Barberán; C Marín; J M Blasco; I Moriyón
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5.  Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child.

Authors:  M Haditsch; L Binder; G Tschurtschenthaler; R Watschinger; G Zauner; H Mittermayer
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

6.  Genome of Ochrobactrum anthropi ATCC 49188 T, a versatile opportunistic pathogen and symbiont of several eukaryotic hosts.

Authors:  Patrick S G Chain; Dorothy M Lang; Diego J Comerci; Stephanie A Malfatti; Lisa M Vergez; Maria Shin; Rodolfo A Ugalde; Emilio Garcia; Marcelo E Tolmasky
Journal:  J Bacteriol       Date:  2011-06-17       Impact factor: 3.490

7.  Morphological responses to nitrogen stress deficiency of a new heterotrophic isolated strain of Ebro Delta microbial mats.

Authors:  Eduard Villagrasa; Neus Ferrer-Miralles; Laia Millach; Aleix Obiol; Jordi Creus; Isabel Esteve; Antonio Solé
Journal:  Protoplasma       Date:  2018-07-09       Impact factor: 3.356

8.  Isolation of bacteria other than Helicobacter pylori from stomachs of squirrel monkeys (Saimiri spp.) with gastritis.

Authors:  S S Khanolkar-Gaitonde; G K Reubish; C K Lee; C T Stadtländer
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

9.  Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi.

Authors:  D Nadjar; R Labia; C Cerceau; C Bizet; A Philippon; G Arlet
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

10.  Ochrobactrum intermedium infection after liver transplantation.

Authors:  L V Möller; J P Arends; H J Harmsen; A Talens; P Terpstra; M J Slooff
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.